Noriko Yamamoto

Title: Noriko Yamamoto: Innovator in Tetrahydroquinoline Compounds

Introduction

Noriko Yamamoto is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of pharmacology, particularly through her work on tetrahydroquinoline compounds. Her innovative research focuses on developing compounds that exhibit therapeutic effects on androgen receptor-mediated diseases.

Latest Patents

Noriko Yamamoto holds 1 patent for her work on tetrahydroquinoline compounds. The patent describes compounds of general formula (I) or pharmacologically acceptable salts that demonstrate a strong binding affinity for androgen receptors (AR). These compounds exhibit AR agonism or antagonism, providing therapeutic benefits without excessive action on the prostate. Instead, they show potent effects on skeletal muscle and bone tissue, making them valuable in treating various conditions.

Career Highlights

Yamamoto is associated with Kaken Pharmaceutical Company, Ltd., where she continues to advance her research. Her work has garnered attention for its potential to improve treatment options for patients suffering from AR-mediated diseases.

Collaborations

Noriko collaborates with esteemed colleagues, including Misa Kamei and Motonori Miyakawa. Their combined expertise enhances the research and development of innovative pharmaceutical solutions.

Conclusion

Noriko Yamamoto's contributions to the field of pharmacology through her patented tetrahydroquinoline compounds highlight her role as a leading inventor. Her work promises to impact the treatment of AR-mediated diseases positively.